Manufacturing and Production

Showing 15 posts of 5882 posts found.

blood

Sobi launches new haemophilia treatment in UK

January 19, 2016 Manufacturing and Production, Sales and Marketing elocta, haemophilia a, sobi

Swedish Orphan Biovitrum Ltd (Sobi) has launched its haemophilia A treatment Elocta (efmoroctocog alfa) in the UK, following its EU …
merck_logo_small

Merck appoints new executive board members

January 19, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck

Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …
stephen_stamp

Ergomed announces board changes

January 19, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …
Eisai logo

FDA grants Eisai’s Lenvima priority review for kidney cancer

January 19, 2016 Manufacturing and Production Breakthrough Therapy Designation, Eisai, FDA, Kidney cancer, Lenvima, lenvatinib, priority review, renal cell carcinoma

The FDA has accepted Eisai’s supplemental New Drug Application (sNDA) for its anti-cancer agent Lenvima for use in the treatment …

Samsung beats pharma to develop first EU-approved Enbrel biosimilar

January 18, 2016 Manufacturing and Production Benepali, CHMP, EMA, Enbrel, Samsung, Samsung Bioepis, etanercept, positive opinion

Samsung Bioepis – the collaboration between Samsung Biologics and Biogen Idec, has become the first company to have a biosimilar …
abbvie

AbbVie replaces retiring VP of Western Europe and Canada

January 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Esteban Plata, Pascale Richetta

AbbVie has appointed Esteban Plata as vice president of Western Europe and Canada.He replaces Pascale Richetta who is retiring from …
Hospira logo

Pfizer may sell off Hospira unit for $2 billion

January 14, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps

Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …
Gavel

US Federal Trade Commission clamps down on pharma ‘pay to delay’ deals

January 14, 2016 Manufacturing and Production, Sales and Marketing Pay to delay, US Supreme Court, antitrust laws, federal trade commission, generic competition, generics, patents, pay for delay

Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …
dr_robert_califf_image_via_duke_university_school_of_medicine

Senate panel approves Dr Robert Califf as FDA commissioner

January 13, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Robert Califf, FDA, FDA commissioner, Senate

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …
Horsham

Former Novartis site to be developed into science park

January 12, 2016 Manufacturing and Production Employment, Jobs, Life science, Novartis, West Sussex, science park

Work has begun to transform a 20-acre site that formerly housed Novartis, in West Sussex, into a world renowned centre …
a

AstraZeneca and MedImmune in oncology research deals

January 12, 2016 Manufacturing and Production, Research and Development AstraZeneca, Incyte, MedImmune, Moderna Therapeutics

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and …
pfizer_logo

Pfizer raised 100 US drug prices 1 January

January 12, 2016 Manufacturing and Production, Sales and Marketing Allergan, Drug pricing, Lyrica, Pfizer, ibrance, tax inversion

Drugs giant Pfizer raised the prices of more than 100 of its drugs in the US on 1 January,  in …
mark_alles_celgene

Mark Alles is new chief executive of Celgene

January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Mark Alles

Celgene president and chief operating officer Mike Alles has been promoted to the top job after an executive restructure at …
DMD

The Pharmafocus debate: Can ultra-orphan drugs be made cheaper?

January 12, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, Duchenne Muscular Dystrophy, Translarne, access to medicines, ataluren, muscular dystrophy, rare disease, ultra orphan drugs, ultra-orphan drugs

The recent reimbursement wrangle between PTC Therapeutics and NICE, the UK healthcare watchdog, has once again raised difficult questions about …
Roche building

Roche snaps up Tensha Therapeutics for up to $535m

January 12, 2016 Manufacturing and Production, Research and Development Roche, Tensha Therapeutics

Roche has acquired Tensha Therapeutics, a privately-held company based in Cambridge, Massachusetts for up to $535 million.The deal that gives …
The Gateway to Local Adoption Series

Latest content